Black Rock Inc. Ligand Pharmaceuticals Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 2,871,496 shares of LGND stock, worth $438 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,871,496

Previous 2,868,270 0.11%

Holding current value

$438 Million

Previous $210 Million 15.4%

% of portfolio

0.01%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$68.53 - $87.91 $221,077 - $283,597	3,226 Added 0.11%	2,871,496 $242 Million
Q1 2024 May 10, 2024	SELL	$68.64 - $89.2 $6.46 Million - $8.39 Million	-94,044 Reduced 3.17%	2,868,270 $210 Million
Q4 2023 Feb 13, 2024	BUY	$49.57 - $72.63 $6.01 Million - $8.8 Million	121,230 Added 4.27%	2,962,314 $212 Million
Q3 2023 Nov 13, 2023	SELL	$58.86 - $72.67 $3.83 Million - $4.73 Million	-65,075 Reduced 2.24%	2,841,084 $170 Million
Q2 2023 Aug 11, 2023	BUY	$69.53 - $79.33 $4.69 Million - $5.35 Million	67,497 Added 2.38%	2,906,159 $210 Million
Q1 2023 May 12, 2023	BUY	$65.67 - $77.08 $3.21 Million - $3.77 Million	48,898 Added 1.75%	2,838,662 $209 Million
Q4 2022 Feb 13, 2023	BUY	$61.72 - $96.74 $7.66 Million - $12 Million	124,146 Added 4.66%	2,789,764 $186 Million
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $392 - $4.22 Million	-39,229 Reduced 1.45%	2,665,618 $230 Million
Q2 2022 Aug 12, 2022	SELL	$74.52 - $117.06 $2.12 Million - $3.33 Million	-28,460 Reduced 1.04%	2,704,847 $241 Million
Q1 2022 May 12, 2022	SELL	$94.99 - $151.56 $902,499 - $1.44 Million	-9,501 Reduced 0.35%	2,733,307 $307 Million
Q4 2021 Feb 10, 2022	BUY	$127.69 - $165.85 $1.48 Million - $1.93 Million	11,614 Added 0.43%	2,742,808 $424 Million
Q3 2021 Nov 09, 2021	BUY	$102.33 - $144.73 $70.3 Million - $99.4 Million	686,816 Added 33.6%	2,731,194 $381 Million
Q2 2021 Aug 11, 2021	BUY	$113.03 - $155.64 $231 Million - $318 Million	2,044,378 New	2,044,378 $268 Million

Others Institutions Holding LGND

# of Institutions

290

Shares Held

19.4M

Call Options Held

Put Options Held

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.58B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account